<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Observational data have shown that the use of <z:chebi fb="0" ids="35664">statins</z:chebi> was associated with a lower prevalence of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We investigated in an academic nursing home the association of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> with atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> (group 1), atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> without <z:hpo ids='HP_0000726'>dementia</z:hpo> (group 2), <z:hpo ids='HP_0000726'>dementia</z:hpo> without atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> (group 3), and no <z:hpo ids='HP_0000726'>dementia</z:hpo> or atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> (group 4) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Increased serum <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) cholesterol was present in 36 of 50 group 1 patients (72%), in 34 of 50 group 2 patients (68%), in 34 of 50 group 3 patients (68%), and in 18 of 50 group 4 patients (36%) (p =.0003 for 1 versus 4; p = 0.001 for 2 versus 4 and 3 versus 4) </plain></SENT>
<SENT sid="3" pm="."><plain>Decreased serum <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol was present in 34 of 50 group 1 patients (68%), in 35 of 50 group 2 patients (70%), in 32 of 50 group 3 patients (64%), and in 16 of 50 group 4 patients (32%) (p =.0003 for 1 versus 4; p =.0001 for 2 versus 4; p =.001 for 3 versus 4) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> was not significantly different in the 4 groups </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The prevalence of increased serum <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> and decreased serum <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> were significantly higher in elderly patients with atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> plus <z:hpo ids='HP_0000726'>dementia</z:hpo>, atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> without <z:hpo ids='HP_0000726'>dementia</z:hpo>, and <z:hpo ids='HP_0000726'>dementia</z:hpo> without atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> than in patients with no <z:hpo ids='HP_0000726'>dementia</z:hpo> or atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
</text></document>